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Loricrin is a major component of the epidermal corniﬁed cell envelope, and is expressed only in terminally dif-
ferentiated keratinocytes. This cell differentiation-specific expression pattern suggests specific suppression of
loricrin gene expression in undifferentiated keratinocytes as well as its activation in differentiated keratinocytes.
We identiﬁed a negative regulatory sequence element in the ﬁrst intron of the mouse loricrin gene involved in
suppression of loricrin gene expression in undifferentiated keratinocytes. A database search indicated that this
sequence contained the putative inverted Yin-Yang 1 (YY1)-binding motif. Constructs with point mutations in the
putative YY1-binding motif showed increased reporter activity, indicating that YY1 negatively regulates loricrin
gene transcription. Co-transfection experiments using a YY1 expression vector revealed that YY1 represses loricrin
promoter activity. Western blotting and immunohistochemical analyses indicated that YY1 is more abundant in
undifferentiated than in differentiated keratinocytes. These ﬁndings suggest that YY1 contributes to specific
loricrin gene expression in differentiated keratinocytes by suppression of its transcription in undifferentiated
keratinocytes. Furthermore, we demonstrated that forced expression of YY1 in differentiated keratinocytes results
in specific downregulation of expression of other early and late differentiation markers.
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The mammalian epidermis is a constantly renewing strat-
ified squamous epithelium. Epidermal keratinocytes are the
major cell type in the epidermis and are responsible for
generating the protective barrier as a consequence of a
tightly regulated, highly compartmentalized differentiation
process that culminates in a mature stratified epidermis
(Roop, 1995). Differentiation proceeds from the basal layer,
through the spinous layer, granular layer, and ultimately the
stratum corneum where fully differentiated keratinocytes
are sloughed off into the environment as flattened squames.
As keratinocytes differentiate into granular-layer cells, they
show induction of late-differentiation products, such as fi-
laggrin (Fisher et al, 1987; Rothnagel et al, 1987), involcrin
(Rice and Green, 1979), and loricrin (Mehrel et al, 1990). This
latter molecule, loricrin, is a major component of the corni-
fied cell envelope, a specialized structure that replaces the
plasma membrane and contributes to the protective barrier
function of the stratum corneum (Koch et al, 2000). Loricrin
is expressed in a keratinocyte- and differentiation-specific
manner (Steven and Steinert, 1994), and in situ hybridization
analyses have shown that loricrin transcripts are localized
only in the upper spinous and granular layers of the ep-
idermis (Mehrel et al, 1990; Hohl et al, 1991b). Loricrin
gene expression is strictly regulated mainly at the level of
transcription. Expression of loricrin has been shown to be
induced on induction of differentiation of cultured keratin-
ocytes by increasing the calcium concentration in the cul-
ture media (Hohl et al, 1991a). Elevation of calcium
concentration in the culture medium triggers differentiation,
as reflected by the expression of differentiation markers,
such as keratins 1 and 10, loricrin, and involucrin. The
calcium switch model thus allows simulation of in vivo dif-
ferentiation. Using this inducible culture system, the tissue-
and differentiation-specific expression of loricrin provides
an ideal experimental model in which to study the tran-
scription factors involved in the control of keratinocyte- and
differentiation-specific gene expression. It has been report-
ed that 6.5 kb of upstream sequence is required for ep-
idermis-specific expression of the mouse loricrin gene, and
an evolutionarily highly conserved activator protein-1 (AP-1)
element in the loricrin proximal promoter is essential but not
sufficient for loricrin expression (DiSepio et al, 1995). Further
experiments demonstrated that the stimulator protein 1
(Sp-1)-binding site located immediately upstream of the AP-
1 site in the loricrin proximal promoter is also essential for
loricrin expression, and molecular interactions of Sp-1/Sp-3
and AP-1 proteins suggest a simple model for regulation of
the loricrin proximal promoter (Y. Kawachi et al, unpublished
Abbreviations: AP-1, activator protein-1; EMSA, electrophoretic
mobility shift assay; Sp-1, stimulator protein 1; YY1, Yin-Yang 1
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data). But the precise mechanism of regulation of specific
loricrin gene expression is still unclear. Little is known about
the molecular mechanism involved in suppression of loricrin
expression in basal epidermal keratinocytes.
In this study, we found that YY1, a constitutive nuclear
member of the GLI-Kru¨ppel family of zinc-finger transcrip-
tion factors, is expressed dominantly in undifferentiated
keratinocytes, and contributes to specific suppression of
loricrin gene expression in undifferentiated keratinocytes.
Furthermore, we report here that Yin-Yang 1 (YY1) also
suppresses the expression of other differentiation marker
proteins, such as keratin 1, keratin 10, and involucrin, in
differentiated keratinocytes.
Results
Identiﬁcation of the negative regulatory element in the
ﬁrst intron of the loricrin gene The expression of loricrin
is strictly linked to keratinocyte differentiation, suggesting
its specific repression in undifferentiated keratinocytes as
well as activation in differentiated keratinocytes. To locate
the negative regulatory sequences involved in suppression
of loricrin gene expression in undifferentiated keratinocytes,
a series of 50 deletions were made and placed upstream of
the luciferase reporter gene. The constructs were analyzed
by transient transfection into primary murine dermal fibro-
blasts or primary murine keratinocytes cultured under either
non-differentiation (0.05 mM Ca2þ ) or differentiation-induc-
ing (0.12 mM Ca2þ ) culture conditions. The loricrin gene
consists of two exons, the 50 non-coding first exon and the
second 30 exon containing the entire coding sequence,
separated by one intron. On transfection into differentiated
keratinocytes, the construct containing the promoter re-
gion, the untranslated first exon, and the first intron
(1.5þ1.1LUC) showed a decrease in reporter activity of
over 50% as compared with those containing only the pro-
moter region (0.3LUC, 0.5LUC, and 1.5LUC) (Fig 1A).
This result suggested that the first intron contains a neg-
ative-acting cis-element.
Further deletion analysis indicated that the region from
þ398 to þ428 is responsible for the suppressive activity of
the first intron (Fig 1B, DEL1-5). A transcription factor da-
tabase search identified a putative inverted-binding motif
for YY1 in this sequence (Fig 1B, DEL5). The point-mutated
constructs with contiguous 2 bp substitutions at the puta-
tive YY1-binding motif showed increases of about 50%
in reporter activity (Fig 1C, MUT/DEL5), indicating that
YY1 negatively regulates loricrin gene transcription in
keratinocytes.
YY1 physically binds to the functional negative element
in the ﬁrst intron of loricrin gene Electrophoretic mobility
shift assays (EMSA) were performed to determine whether
YY1 actually binds to the functional negative element. A
fragment of 25 bp derived from the negative element in the
first intron was used as a probe. One distinct DNA/protein
complex was detected using nuclear extracts prepared
from epidermal keratinocytes (Fig 2, lane 1). Pre-incubation
with 100-fold molar excess of an unlabeled wild-type
oligonucleotide inhibited complex formation (Fig 2, lane 3).
Pre-incubation with even a 100-fold molar excess of un-
labeled mutant oligonucleotide with 2 bp contiguous sub-
stitutions within the negative element failed to inhibit
complex formation (Fig 2, lanes 4 and 5). Unlabeled
oligonucleotides containing a typical YY1 consensus-bind-
ing site completely inhibited complex formation (Fig 2, lanes
6 and 7). To confirm more directly that YY1 protein binds
to the negative element, we added a polyclonal antibody
against YY1 to the protein extracts in these EMSA. As
shown in Fig 2 (lanes 8 and 9), anti-YY1 antibody inhibited
protein/DNA complex formation and generated supershifted
bands. These experiments clearly demonstrated that YY1
can bind to the functional negative element in the first intron
of the loricrin gene. Another shifted band (indicated by as-
terisks in Fig 2) was observed that competed with the wild
type but not the mutant oligonucleotide. Interestingly, the
typical YY1 consensus oligonucleotide did not compete
with this band. These findings suggest that a DNA-binding
factor other than YY1 also binds to the sequence of the
negative regulatory element.
YY1 expression is downregulated during keratinocyte
differentiation Immunohistochemical staining of the epi-
dermis was performed to investigate epidermal YY1 ex-
pression in vivo. YY1 was strongly expressed mainly in the
cytoplasm in cells of the basal epidermal layer, whereas its
expression was weak in the suprabasal layers (Fig 3A). To
examine the changes in the level of YY1 protein in keratin-
ocytes during differentiation, western blotting analysis was
performed using nuclear extracts prepared from undiffer-
entiated and differentiated keratinocytes. As shown in Fig
3B, YY1 was more abundant in the nuclear extracts of cells
grown under non-differentiation (0.05 mM Ca2þ ) than dif-
ferentiation-inducing conditions (0.12 mM Ca2þ ). To con-
firm downregulation of the DNA-binding activity of YY1 by
keratinocyte differentiation, the nuclear extracts of cells
grown under non-differentiation and differentiation-inducing
conditions were analyzed by EMSA. As shown in Fig 3C, the
intensity of the shifted band was much higher in the lanes
containing nuclear extracts from cells grown under non-dif-
ferentiation (0.05 mM Ca2þ ) than differentiation-inducing
conditions (0.12 mM Ca2þ ). These observations indicated
that the DNA-binding activity of YY1 was elevated in
undifferentiated keratinocytes and downregulated in differ-
entiated keratinocytes. This differentiation-dependent
downregulation of YY1 expression suggested that YY1
contributes to the specific expression of loricrin gene in
differentiated keratinocytes by suppression of its transcrip-
tion in undifferentiated cells.
Overexpressed YY1 functionally suppresses loricrin
promoter activity To determine the specific functional
effect of YY1 on loricrin gene transcriptional activity in
keratinocytes, transient co-transfection experiments were
performed in cultured keratinocytes. The loricrin reporter
construct p0.5–1.1Luc containing 0.5 kb of 50-flanking
region and 1.1 kb of the first intron was transfected
into keratinocytes grown under non-differentiation or
differentiation-inducing conditions in the presence of the
YY1 expression vector pCMV-YY1 or control empty vector.
As shown in Fig 4, YY1 decreased loricrin reporter activity
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to less than 30% of the control level in both undifferen-
tiated and differentiated keratinocytes. Thus, YY1 was
shown to act as a potent negative regulator of loricrin gene
expression.
YY1 decreases expression of keratinocyte differentia-
tion marker genes Next, we analyzed the effects of YY1 on
expression of endogenous differentiation marker genes in
keratinocytes grown in low- or high-calcium medium. West-
ern blotting analysis was used to monitor expression of the
basal markers keratins 5 and 14, the early differentiation
markers keratins 1 and 10, and the terminal differentiation
markers involucrin and loricrin. Differentiating keratinocytes
in the presence of a high level of calcium (0.12 mM) and
terminally differentiated keratinocytes in the presence of a
very high-calcium level (0.35 mM) showed marked decreases
Figure 1
Identification of negative elements
in the first intron of the loricrin gene.
(A) Transient expression of the luciferase
reporter gene under the control of
the mouse loricrin 50-upstream sequence.
Plasmids containing serial deletions of
the loricrin gene 50-flanking region
(1.5Luc, 0.5Luc, and 0.3Luc) or con-
taining 0.5 kb of 50-flanking sequence and
1.1 kb of the first intron (0.5þ 1.1Luc)
linked to reporter vectors carrying the
firefly luciferase gene (Luc) were tran-
siently transfected into differentiated ker-
atinocytes cultured in high-calcium
medium (0.12 mM Ca2þ ; black bars), un-
differentiated keratinocytes cultured in
low-calcium medium (0.05 mM Ca2þ ;
open bars), or normal dermal fibroblasts
(dotted bars). The vector nomenclature is
based on the length of the 50-loricrin se-
quence in each construct (e.g., 1.5Luc
contained sequences from positions þ1
bp to 1.5 kb). Cells were harvested
and assayed for luciferase activity as de-
scribed in Materials and Methods. Error
bars represent one standard deviation
of triplicate transfections. Differences in
transfection efficiency were normalized
relative to sea pansy luciferase activity
produced by the co-transfected pRL-tk
vector. The relative luciferase activities
shown are the ratios of firefly luciferase
activities derived from pGL3-loricrin pro-
moter constructs to sea pansy luciferase
activities from the pRL-tk vector. (B) Iden-
tification of an element that is critical for
the negative activity of the first intron.
Plasmids containing various deletions in
the first intron of the loricrin gene (DEL1-5)
or the wild-type (WT) first intron ligated
into reporter cassettes carrying the firefly
luciferase gene (Luc) were transiently
transfected into differentiated keratin-
ocytes. The arrow at DEL5 indicates the
critical region (398–428) for the negative
activity of the first intron. Relative lucif-
erase activity was as defined in (A). (C)
Effects of the Yin-Yang 1 (YY1)-binding
motif on negative transcriptional activity
of the first intron. Differentiating keratin-
ocytes were transfected with DEL5 or
mutated reporter plasmid with contiguous
2 bp point mutation in the YY1 motif
(MUT/DEL5). Mutated sequences in YY1-
binding motifs (TG to CA) are shown in
closed boxes.
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in the expression of the early and terminal differentiation
markers after transfection with YY1 expression vector, re-
spectively. Interestingly, there were no differences in the
expression of the basal keratinocyte markers keratin 5 or 14
by transfection of YY1. Therefore, forced expression of YY1
in differentiated keratinocytes resulted in downregulation of
early and terminal differentiation markers, indicating that the
early and late differentiation markers are specifically sup-
pressed in differentiated keratinocytes in a YY1-dependent
manner.
Discussion
A number of regulatory elements and transcription factors
have been shown to be involved specifically in the regula-
tion of cell type- or differentiation-specific epidermal gene
expression. Several ubiquitous transcription factors, such
as AP-1, AP-2, Sp-1/3, and NF-kB, have been shown to be
involved in the regulation of the epidermal gene expression
(Eckert et al, 1997a, b). It is interesting that ubiquitously ex-
pressed transcription factors appear to control the specific
expression of epidermal genes. The AP-1 site 6.5 kb up-
stream of the cap site is essential for epidermis-specific
mouse loricrin gene expression (DiSepio et al, 1995). A re-
cent study indicated that synergistic interactions among
multiple transcription factors are important for keratinocyte-
specific expression of the human loricrin gene (Jang and
Steinert, 2002). The mechanisms and factors involved in
the specific suppression of loricrin gene expression in
Figure 2
Yin-Yang 1 (YY1) binds specifically to the putative negative motifs
in intron 1 of the loricrin gene. Electrophoretic mobility shift assays
were performed using radiolabeled wild-type oligonucleotide contain-
ing the putative YY1-binding motif and nuclear extracts from epidermal
keratinocytes. Incubations were carried out in the presence or absence
of a 10-fold or a 100-fold excess of unlabeled wild-type oligonucleotide
(lanes 2 and 3), mutant oligonucleotide (lanes 4 and 5), or typical YY1-
binding consensus oligonucleotide (lanes 6 and 7). Nuclear extracts
were pre-incubated with 1 mg (lane 8) or 2 mg (lane 9) of anti-YY1
antibody followed by incubation with radiolabeled wild-type probe. The
arrowhead indicates a potential supershifted band. Pre-incubation with
anti-actin antibody was also performed to confirm the specificity of the
anti-YY antibody (right panel). The protein–DNA complexes were sep-
arated by polyacrylamide gel electrophoresis. The specific band cor-
responding to YY1–DNA complex is indicated by an arrow. The faster
moving band, which showed partial competition with the wild-type and
YY1 consensus oligonucleotides but not the mutant oligonucleotide, is
indicated by an asterisk.
Figure3
Expression profile of Yin-Yang 1 (YY1) protein in epidermis and
cultured keratinocytes. (A) Expression of YY1 in stratified epithelium
in vivo. Frozen sections of murine neonatal back skin were immuno-
stained with an antibody to YY1. The dotted line represents the base-
ment membrane zone. CL, cornified layer; SL, squamous layer; BL,
basal layer; DE, dermis. (B) Changes in expression of YY1 through
differentiation of cultured keratinocytes. Nuclear extracts from cultured
undifferentiated (0.05 mM Ca2þ ) and differentiated (0.12 mM Ca2þ )
keratinocytes were examined for YY1 protein expression by western
blotting analysis. Equivalent quantities of extract were subjected to
polyacrylamide gel electrophoresis and transferred onto nitrocellulose
membranes. The membranes were incubated with anti-YY1 antibody
(upper panel). As an internal reference for relative amounts of protein,
the blots were re-probed using anti-lamin A/C antibody (lower panel).
(C) Changes in DNA-binding activity of YY1 through differentiation of
cultured keratinocytes. Electrophoretic mobility shift assays were per-
formed using nuclear extracts from cultured undifferentiated (0.05 mM
Ca2þ , lanes 1 and 2) and differentiated (0.12 mM Ca2þ , lanes 3 and 4)
keratinocytes. Nuclear extracts from cultured undifferentiated (lanes 5
and 6) and differentiated (lanes 7 and 8) keratinocytes were pre-incu-
bated with 1 mg of anti-YY1 antibody followed by incubation with
radiolabeled wild-type probe.
Figure4
Yin-Yang 1 (YY1) suppresses loricrin promoter activity in tran-
siently transfected keratinocytes. The loricrin reporter construct
p0.5–1.1Luc, which contains 0.5 kb of 50-flanking region and 1.1 kb of
intron 1, was transfected into non-differentiating or differentiating ker-
atinocytes in the presence of YY1 expression vector, pCMV-YY1, or
control empty vector. Open bars indicate the luciferase activity of the
corresponding constructs in undifferentiated keratinocytes grown in
low-calcium medium (0.05 mM Ca2þ ). Black bars indicate luciferase
activity in differentiated keratinocytes grown in high-calcium medium
(0.12 mM Ca2þ ).
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basal undifferentiated keratinocytes, however, remain to be
elucidated.
To identify the negative elements involved in the regula-
tion of loricrin expression in undifferentiated keratinocytes,
we investigated the functional role of the first intron. Our
results identified a YY1-binding motif in the first intron as a
negative regulatory element. In this study, we showed that
YY1 is expressed at high levels in the epidermal basal layer
and that it suppresses transcription of the loricrin gene in
basal undifferentiated keratinocytes.
YY1 is a member of the GLI-Kru¨ppel family of transcrip-
tion factors and several lines of evidence suggest that YY1
is a multifunctional transcriptional regulator, involved in in-
itiation, activation, or repression of transcription depending
on both the promoter and cellular context. YY1 mRNA and
protein have been identified in a number of different tissues
and cell types, suggesting that it is expressed both consti-
tutively and ubiquitously (Shi et al, 1997). But YY1 expres-
sion level increases rapidly in quiescent NIH3T3 cells in
response to serum and insulin-like growth factor-1 (Flan-
agan, 1995). YY1 DNA-binding activity has also been shown
to be regulated during differentiation. For example, YY1
DNA-binding activity decreases during differentiation of hu-
man teratocarcinoma cells (Liu et al, 1994) and in myoblast
differentiation (Lee et al, 1992), but increases during aging
(Adrian et al, 1996). In addition to differentiation-specific
gene regulation, a recent study also indicated that YY1
contributes to the T cell-specific expression pattern of
CD3delta (Ji et al, 2002). The results of this study indicate
that YY1 protein is expressed at high levels in undifferen-
tiated basal keratinocytes and is downregulated during
differentiation both in vivo and in vitro. The level of YY1
DNA-binding activity also decreased markedly during dif-
ferentiation, suggesting that YY1 may regulate undifferen-
tiated keratinocyte-specific gene expression. As YY1
protein is degraded by the calcium-activated protease cal-
pain II and the 26 S proteosome during myoblast differen-
tiation (Walowitz et al, 1998), the calcium-dependent, post-
translational proteolytic mechanism might be important for
the specific inactivation of YY1 during keratinocyte differ-
entiation. In this study, we showed that YY1 bound to the
negative regulatory element in intron 1 of the loricrin gene
and functionally repressed loricrin gene transcriptional ac-
tivity. Taken together, our findings indicate that YY1 con-
tributes to the specific suppression of loricrin gene
expression in undifferentiated keratinocytes. Furthermore,
we demonstrated that the overexpression of YY1 in kera-
tinocytes cultured under differentiation-inducing conditions
resulted in marked decreases in the expression of not only
loricrin but also of the other early and late differentiation
marker genes, keratin 1, keratin 10, and involucrin, whereas
the levels of expression of the undifferentiated marker
genes keratins 5 and 14 were relatively unaffected. These
findings suggest that YY1 plays an important role in main-
tenance of the undifferentiated phenotype in keratinocytes.
A functional YY1-binding site was identified 1.9 kb up-
stream of the human keratin 1 gene (J. S. Lee et al, un-
published data) and our database search indicated that
human and mouse keratin 10 genes have a possible YY1-
binding site in their promoter regions. But the promoter re-
gions of keratins 5 and 14 genes contain no putative YY1-
binding sites. YY1 has been implicated in the repression of
genes that are intimately involved in various differentiation
processes (Shrivastava and Calame, 1994). Repression of
gene expression by YY1 may ensure correct temporal
and spatial expression of differentiation-specific molecules
(Raich et al, 1995). The relief of YY1 repression of the skel-
etal a-actin promoter is thought to be important in myoblast
differentiation (Lee et al, 1992). The globin gene switch
process during hematopoiesis has been suggested to in-
volve YY1 (Orkin, 1995). The ability of ubiquitous YY1 to
suppress differentiation-specific gene expression may be
because of its ability to antagonize differentiation-specific
transcriptional activators. In addition, activation of cell cy-
cle-related genes, such as c-Myc, by YY1 may contribute to
the repression of differentiation-specific gene expression
(Riggs et al, 1993).
YY1 has been shown to regulate the gene transcription
through physical and functional interactions with various
Figure 5
Effects of Yin-Yang 1 (YY1) overexpression on the expression of
keratinocyte differentiation markers. Total cell extracts from undif-
ferentiated keratinocytes or differentiated keratinocytes transfected
with YY1 expression vector or vehicle vector were analyzed by
immunoblotting with specific antibodies for the indicated proteins: (A)
basal keratinocyte markers, keratins 5 and 14; (B) early differentiation
markers, keratins 1 and 10; (C) terminal differentiation markers, in-
volucrin, and loricrin. Undifferentiated keratinocytes were grown in low-
calcium medium (0.05 mM Ca2þ ), and differentiated keratinocytes
were grown in high- or very high-calcium media (0.12 mM per 0.35 mM
Ca2þ , respectively). NT, non-transfected keratinocytes; YY1, trans-
fected with YY1 expression vector pCMV-YY1; vehicle, transfected
with empty vehicle vector pCMV.
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transcription factors and co-factors. The specific actions
of the ubiquitously expressed factor YY1 can be largely
explained by its interactions with a diverse array of other
sequence-specific factors and co-factors (Shi et al, 1997). A
number of epidermal key regulatory proteins, such as Sp-1,
C/EBPb, and CBP/p300, have been shown to interact with
YY1 (Lee et al, 1993; Bauknecht et al, 1996; Thomas and
Seto, 1999), suggesting that these interactions are impor-
tant in determining the particular function of YY1 at a given
promoter. Regulation of human loricrin gene expression has
been shown to require interactions among a number of
ubiquitous transcription factors, the fine balance of the
availability of these proteins, and recruitment of the co-ac-
tivator p300/CBP (Jang and Steinert, 2002). Previously, we
reported that both AP-1 and Sp-1/Sp-3 elements located
14–40 bp upstream from the TATA box are crucial for dif-
ferentiation-specific murine loricrin gene expression and
that they interact both functionally and physically with each
other (unpublished data). Our findings suggested that AP-1
and Sp-1/Sp-3 proteins form a core transcription complex
that can strongly activate transcription from the loricrin gene
promoter in differentiated keratinocytes. Thus, the repres-
sion of loricrin transcription by YY1 in undifferentiated ker-
atinocytes may be because of the coordinated interaction
between YY1 and the core transcription complex com-
posed of AP-1 and Sp-1.
Materials and Methods
Plasmids The isolation and characterization of a 14 kb genomic
loricrin gene fragment has been reported elsewhere (DiSepio et al,
1999). A 2.6 kb loricrin genomic fragment containing 1.5 kb of
upstream regulatory sequence, the TATA box, 47 bp of the un-
translated exon 1, and 1.1 kb of intron 1 was inserted into the
plasmid pGL3-basic (Promega, Madison, Wisconsin) in-frame with
the promoter-less luciferase reporter cassette (firefly luciferase) to
generate 1.5–1.1LOR. To obtain a series of intron 1 deletion con-
structs, 1.5–1.1LOR was subjected to EcoRV/NsiI digestion, which
eliminated a 371 bp fragment yielding the construct DEL1, and
PstI/EcoRV digestion, which eliminated a 374 bp fragment yielding
the construct DEL2 (Fig 1). To generate constructs DEL3, DEL4,
and DEL5, the specific fragments between the PstI and EcoRV
sites in intron 1 were amplified by PCR using 50 primers corre-
sponding to positions 200, 250, or 300 bp upstream from the
EcoRV site, each of which contained an artificial PstI site. PCR was
performed using the common 30 primer that included the EcoRV
site. The PCR product was ligated with the DEL2 construct di-
gested with PstI and EcoRV (Fig 1). For point mutagenesis of the
YY1 recognition site, the 50 primer with an artificial PstI site and a
point mutation on the YY1 recognition sequence (Fig 1, MUT) was
generated. PCR and ligation reactions were performed using 50
PstI I and 30 EcoRV sites as described above. The mammalian
expression vector pCMV-YY1 was kindly provided by Dr Yang Shi
(Harvard Medical School, Boston, Massachusetts). All deletions
and mutations were confirmed by DNA sequencing.
Cell culture and transient cell transfection Primary mouse ker-
atinocyte cultures were prepared as described previously (Rot-
hnagel et al, 1993). Primary keratinocytes were isolated and then
grown in low-calcium medium (0.05 mM calcium, 50% fibroblast-
conditioned medium; Harper et al, 1988; Rothnagel et al, 1993, 8%
fetal calf serum (FCS) in Dulbecco’s modified Eagle’s medium
(DMEM) (BioWhittaker, Walkersville, Maryland)) for 48 h prior to
transfection. Then, keratinocytes were cultured in either high-cal-
cium medium (0.12 mM calcium, 50% fibroblast-conditioned me-
dium, 8% FCS in DMEM) or in low-calcium medium. In induction of
terminal differentiation, keratinocytes were still more cultured in
very high-calcium medium (0.35 mM calcium, 50% fibroblast-con-
ditioned medium) for 24 h after culture in high-calcium medium.
Low-calcium medium was supplemented with 4.0 ng per mL
of epidermal growth factor (EGF) (Becton Dickinson, Bedford,
Massachusetts) unless otherwise indicated. Mouse dermal fibro-
blasts were cultured in DMEM supplemented with 10% FCS. Cells
were transfected using the LT1 reagent in accordance with the
manufacturer’s recommendations (Panvera, Madison, Wisconsin).
To examine expression in undifferentiated keratinocytes, cells were
cultured in low-calcium medium for 48 h after transfection and
then harvested. Expression in differentiated keratinocytes was
assessed by growing transfected cells for 24 h in low-calcium
medium without EGF, followed by 2 d in high-calcium medium. To
determine transfection efficiencies and to normalize expression
levels, all cultures were co-transfected with plasmid pRL-TK
(Promega). This plasmid contains the Renilla luciferase gene un-
der the control of the herpes simplex virus TK promoter. Luciferase
assays were performed using a dual-luciferase assay kit according
to the manufacturer’s protocol (Promega). Firefly and sea pansy
luciferase activities were measured with a Monolight 2020 lumino-
meter (Analytical Luminescence Laboratory, Ann Arbor, Michigan).
Each construct was tested in triplicate.
EMSA Whole-cell extracts were obtained from dissociated epi-
dermal keratinocytes. Cells were washed with phosphate-buffered
saline (PBS), resuspended in storage buffer (20 mM HEPES, pH
7.8, 400 mM KCl, 20% glycerol, 2 mM dithiothreitol), and then
frozen in a dry ice/ethanol bath. Supernatants were thawed on ice,
centrifuged at 15,000  g, and aliquoted. Nuclear extracts were
prepared from differentiated or undifferentiated keratinocytes as
described previously (Schreiber et al, 1989). Protein concentrations
were determined with a Bradford assay kit (BioRad, Hercules,
California), and equal amounts of protein were used for each DNA/
protein-binding reaction. Oligonucleotides were end labeled using
32P-ATP and T4 polynucleotide kinase (Invitrogen, Carlsbad, Cal-
ifornia) according to the manufacturer’s instructions. Labeled
probes (2 ng; 105–106 c.p.m.) were incubated with 1–3 mg of cell
extract for 15–30 min on ice. In some experiments, 1 mg per re-
action of anti-YY1 antibody (sc-1703X; Santa Cruz Biotechnology,
Santa Cruz, California) was added. The DNA/protein complexes
were analyzed by native polyacrylamide gel electrophoresis (PAGE)
and visualized by autoradiography of the dried gels. The sequence
of radiolabeled oligonucleotide for YY1 binding corresponded to
the region of þ 400 to þ 425 on the first intron of the loricrin gene.
The sequence of the mutant YY1-binding oligonucleotide is shown
in Fig 1C as MUT. Oligonucleotides with the consensus-binding
sequence for cold competition experiments and anti-actin anti-
body (sc-7210) as a control antibody for supershift assay were
purchased from Santa Cruz Biotechnology (sc-2533).
Immunohistoﬂuorescence staining Immunohistofluorescence
staining was performed using an antibody to YY1 (sc-1703, San-
ta Cruz Biotechnology). Skin specimens obtained from neonatal
mice were embedded in Tissue-TekII OCT compound (Sakura
Finetek, Torrance, California) and frozen. Sections, 5 mm thick,
were cut on a cryostat, and placed on uncoated slides. For stain-
ing, slides were incubated with primary antibody for 30 min,
followed by washing with PBS. Slides were incubated with fluo-
rescein isothiocyanate-conjugated secondary antibody (sc-2012;
Santa Cruz Biotechnology), mounted, and then analyzed by fluo-
rescence microscopy (Nikon, Tokyo, Japan).
Immunoblotting analysis Whole-cell extracts were prepared
from differentiated or undifferentiated keratinocytes. Nuclear ex-
tracts were prepared from differentiated or undifferentiated kera-
tinocytes as described previously (Schreiber et al, 1989). For
western blotting analysis of the expression of pCMV-YY1, whole-
cell extracts from the transfected keratinocytes were obtained 48 h
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after transfection. Proteins were separated by 8.5%–10% SDS-
PAGE and then transferred onto nitrocellulose membranes
(Schleicher & Schuell, Dassel, Germany). Blots were probed suc-
cessively with antibodies to YY1 (sc-281; Santa Cruz Biotechnol-
ogy), keratin 14 (PRB-155P; Covance, Richmond, California),
keratin 5 (PRB-160P; Covance), involucrin (PRB-142C; Covance),
and loricrin (PRB-145P; Covance). After detection of primary an-
tibody binding, blots were stripped using ImmunoPure IgG elution
buffer (Pierce Chemical Company, Rockford, Illinois). Primary an-
tibody binding was detected using PicoWest SuperSignal ECL
Substrate (Pierce) and exposure to Biomax MR film (Kodak,
Rochester, New York).
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